In this activity, Prof. Dr. med. Jan BeyerWestendorf addresses the issue of reversal strategies in patients with direct oral anticoagulantassociated intracranial haemorrhage (DOACICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guidelinedirected management of the condition.

Learn more here: https://touchneurologyime.org/intracr...

Or

Sign up now to stay informed: https://touchneurology.com/yourfree...

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.